Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 33: | Line 33: | ||
==[[Neuroendocrine tumors screening|Screening]]== | ==[[Neuroendocrine tumors screening|Screening]]== | ||
==[[Neuroendocrine tumors natural history|Natural History, Complications and Prognosis]]== | ==[[Neuroendocrine tumors natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
Revision as of 20:34, 30 August 2012
| Neuroendocrine tumors | |
| ICD-9 | 209 |
|---|---|
| ICD-O: | M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 |
| MeSH | D018358 |
|
Neuroendocrine tumors Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Neuroendocrine tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Endoscopy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
External links
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.